Qualifol 150 IU

Urofollitropin, also known as follicle-stimulating hormone (FSH), is a medication utilized in assisted reproductive technologies to stimulate the ovaries and promote the development of mature eggs in women. It is a purified form of FSH, a hormone naturally produced by the pituitary gland that plays a crucial role in the menstrual cycle and the growth of ovarian follicles.

In fertility treatments, Urofollitropin is often prescribed to women who experience ovulatory dysfunction or infertility due to inadequate FSH levels. By administering exogenous FSH, Urofollitropin helps stimulate the growth and development of ovarian follicles, each of which contains an immature egg. This process, known as ovulation induction, increases the likelihood of successful ovulation and the release of mature eggs for fertilization.

Urofollitropin is typically administered via injection and requires close monitoring by a fertility specialist to adjust dosage and timing based on individual response. It may be used alone or in combination with other fertility medications, such as gonadotropin-releasing hormone (GnRH) agonists or antagonists, to optimize ovarian stimulation and improve the chances of conception.

While generally well-tolerated, Urofollitropin may cause side effects such as injection site reactions, abdominal discomfort, or ovarian hyperstimulation syndrome (OHSS), particularly in cases of excessive ovarian response. OHSS is characterized by swollen and painful ovaries, along with symptoms such as nausea, vomiting, and fluid retention.

Overall, Urofollitropin offers an effective option for women undergoing fertility treatments by helping to stimulate ovarian follicle growth and enhance ovulation, increasing the chances of successful conception. However, its use should be carefully monitored by a qualified healthcare provider to minimize potential risks and optimize outcomes.